Sources & References
Peer-reviewed research
Once-weekly cagrilintide for weight management in people with overweight and obesity: a phase 2 trial
Research FAQ
Compound and research-use information
What is Cagrilintide?
Cagrilintide is a synthetic long-acting peptide research compound that acts as an amylin-receptor and calcitonin-receptor agonist. It is supplied strictly for laboratory research use.
What is Cagrilintide studied for in the research setting?
Cagrilintide is studied in vitro and in preclinical models as a reference amylin / calcitonin receptor agonist to investigate amylin-pathway receptor signaling in cell and animal systems. It is used only as a mechanistic research tool.
What form is Aurevena's Cagrilintide supplied in?
Cagrilintide is supplied as a lyophilized (freeze-dried) powder. Every batch is tested by independent, accredited U.S. laboratories for purity and identity, with the Certificate of Analysis published on this product page. Store lyophilized peptide cold and protected from light, and avoid repeated freeze-thaw cycles.
Is Cagrilintide intended for human use?
No. Cagrilintide is sold by Aurevena strictly for laboratory and research use only. It is not a drug, dietary supplement, cosmetic, or medical device, and is not intended for human or veterinary use, consumption, or for the diagnosis, treatment, cure, or prevention of any disease.





